Empowering early-phase drug discovery

Silicos is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases.
Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets.

News

05-Jul-2008	Silicos launches new website.
May-2008	Silicos and Movetis start collaboration.
Spring-2008	Silicos strengthens team with experienced modelers and biologist.
Apr-2008	Silicos publishes Pharao tool in Journal of Molecular Graphics and Modeling.

Upcoming Events

31-08-Aug-2008	XXth International Symposium on Medicinal Chemistry.
02-04-Jul-2008	Bio Expo 2008, Tokyo, Japan.
19-20-Jun-2008	Virtual Discovery 2008, Amsterdam, the Netherlands.
17-20-Jun-2008	BIO 2008, San Diego, USA.
8-Jun-2008	Knowledge for Growth 2008, Ghent, Belgium.